Premium
Delayed Presentation of Low Molecular Weight Heparin Treatment Failure in a Patient With Mitral Valve Prosthesis
Author(s) -
Stamou Sotiris C.,
Lefrak Edward E.
Publication year - 2007
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/j.1540-8191.2007.00343.x
Subject(s) - medicine , low molecular weight heparin , prosthesis , heparin , surgery , complication , thrombosis , mitral valve , presentation (obstetrics) , mitral valve replacement , cardiology
We describe a patient who developed right basal ganglion stroke and partial obstruction of St. Jude mitral valve prosthesis as a result of treatment failure with enoxaparin. The patient did not develop the embolic complication from the thrombosis until almost 4 months after the bridging sequence with low molecular weight heparin. The patient underwent thrombectomy of the mitral valve. At least 16 similar cases with mechanical valve prostheses and treatment failure of low molecular weight heparin have been reported.